In a rodent pressure-overloaded HF model, EPA inhibited the transforming growth factor-beta 1 (TGF-β1) pro-fibrotic pathway via FFR signaling in cardiac fibroblasts and suppressed the entire cardiac fibrosis without requirement of EPA localization into the cellular membrane [72]. The gene discussed is TGFB1; the disease is hydrops fetalis.